Dr. Alex Mejia Garcia is a board-certified hematologist at the Scully-Welsh Cancer Center at Cleveland Clinic Indian River Hospital. Dr. Mejia Garcia specializes in treating chronic lymphocytic leukemia, lymphoma and multiple myeloma.
Dr. Mejia Garcia completed a fellowship in cancer drug development at UT Health San Antonio MD Anderson Cancer Center. During that time, he directed the early-phase drug development for a hematological malignancies program at that institution. He also holds formal and specific training in clinical pharmacology and early phase drug development from Thomas Jefferson University, and he has served as the conducting principal investigator in several national clinical trials and in industry-sponsored trials for new lymphoma drugs. His research has been featured in numerous peer-reviewed publications.
Dr. Mejia Garcia takes a holistic, team-oriented and patient-centered approach to cancer treatment. He considers not only the disease state, but also each person’s overall health, social support network, culture and treatment goals. He utilizes the latest in cancer research to provide the best possible treatment options and is passionate about making a positive impact in the lives of his patients and their families.
